Anavex Life Sciences Corp (AVXL)

[stealthways]

Au much cheaper phase 2/3; Why?
In the US AD trials have a very poor success rate (since targeting AD plague always) and this is partly why the infrastructure supporting US AD trials is profit bloated .... to the point that hard costs in us are likely half of final costs per patient.... Other reasons for high US costs of AD P3 trials likely stem from a general wealthier economy and dominant bio industry in the US,,, Rationalize in your head why an AD trial should cost 150 million for 300 patients --- when thinking of hard costs you can not, its absurd ?
The structure of the US health system may also contribute to the high trial costs in same...

Doing the Phase 2/3 in Au would be both brilliant and simple .. I could see AVXL getting a trial done at below US hard costs, and possibly much more due to nice subsidies in Au.... $13K per patient is in the range IMO...

In summary doing the two smaller trials in the US (with grant money) and AD in Au (at costs below hard costs) is brilliant and a great financial hedge (to avxl) against the bashing it has endured.....